SCHEMBL14901093

SCHEMBL14901093

CCc1cccc2c1C(=O)C(=C=O)C(=O)N2C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.38
TTR P02766 1/20 0.38
CES1 P23141 1/20 0.38
MGLL Q99685 1/20 0.37
GABRA1 P14867 3/20 0.34
GABRB2 P47870 3/20 0.34
LMNA P02545 3/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HTR1A P08908 1/20 0.34
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
DRD3 P35462 1/20 0.34
ANPEP P15144 1/20 0.33
DPP4 P27487 1/20 0.33
BRD4 O60885 1/20 0.32
NPEPPS P55786 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28074698 0.84 TTR (0.48) TP53TTRCES1MGLLGABRA1
SCHEMBL10045010 0.82 TTR (0.47) TP53TTRCES1MGLLGABRA1
SCHEMBL9728198 0.69 MGLL (0.42) TP53MGLLGABRA1GABRB2LMNA
SCHEMBL28490612 0.69 NR1H2 (0.54) TTRCES1ALDH1A1ALDH2ALDH3A1
SCHEMBL13607734 0.66 PARP1 (0.40) TTRCES1LMNAMAPTMEN1
SCHEMBL13671328 0.65 MEN1 (0.60) MAPTMEN1KMT2AANPEPDPP4
SCHEMBL28551734 0.63 MGLL (0.36) TP53MGLLGABRA1GABRB2LMNA
SCHEMBL7756746 0.63 TTR (0.52) TTRCES1MGLLLMNAMEN1
SCHEMBL29717667 0.61 ALDH1A1 (0.44) TP53CES1MGLLMAPTMEN1
SCHEMBL15206754 0.61 TTR (0.50) TTRCES1MGLLLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871936-B2 Method for manufacturing of quinoline-3-carboxamides ACTIVE BIOTECH AB (SE) 2014-10-28 US disclosed
US-20130109860-A1 METHOD FOR MANUFACTURING OF QUINOLINE-3-CARBOXAMIDES ACTIVE BIOTECH AB (SE) 2013-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109860-A1 METHOD FOR MANUFACTURING OF QUINOLINE-3-CARBOXAMIDES ADH1A, ADH5, ADH1C TP53 4660/4885TTR 1922/4885CES1 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.